We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketWe will openupinternationalsites forMino-Lok trialMino-WrapOnly biotechwith 2 Myron'son theleadershipteamMino-Lokis our leadassetWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsThere are noFDAapproveddrugs to treathemorrhoidsOur Halo-Lido trial willhave finalpatient byend of 2022I won't diluteshareholdersI'm ashareholdermyselfI/Ontak isour leadassetMino-Lokpotentialmarket>$1BAn actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013I/ONTAKwas thebest deal Iever madeWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mWe willhaveexclusivityWe had aphase 2btrial with100%efficacyInsidersinvested$26.5mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearHemorrhoidsis a $2BmarketWe will openupinternationalsites forMino-Lok trialMino-WrapOnly biotechwith 2 Myron'son theleadershipteamMino-Lokis our leadassetWe intendto submita BLA in2H 2022The name Citiuscomes from theOlympic motto"Citius,AltiusForius"Not manycompaniesthis size with2 late stageassetsThere are noFDAapproveddrugs to treathemorrhoidsOur Halo-Lido trial willhave finalpatient byend of 2022I won't diluteshareholdersI'm ashareholdermyselfI/Ontak isour leadassetMino-Lokpotentialmarket>$1BAn actualiMSCupdateMyron Holubiakand I founded aprivatecompany in2013I/ONTAKwas thebest deal Iever madeWe haveenough cashto go wellinto 2023I/ONTAK'spotentialmarket is>$300mWe willhaveexclusivityWe had aphase 2btrial with100%efficacyInsidersinvested$26.5mI/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.

Leonard Mazur HCW Conference BINGO - Call List

(Print) Use this randomly generated list as your call list when playing the game. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
B
2
O
3
B
4
N
5
G
6
I
7
O
8
O
9
I
10
I
11
B
12
G
13
G
14
G
15
G
16
B
17
O
18
I
19
O
20
N
21
I
22
N
23
B
24
N
  1. B-We expect to finish the Mino-Lok trial this year
  2. O-Hemorrhoids is a $2B market
  3. B-We will open up international sites for Mino-Lok trial
  4. N-Mino-Wrap
  5. G-Only biotech with 2 Myron's on the leadership team
  6. I-Mino-Lok is our lead asset
  7. O-We intend to submit a BLA in 2H 2022
  8. O-The name Citius comes from the Olympic motto "Citius,Altius Forius"
  9. I-Not many companies this size with 2 late stage assets
  10. I-There are no FDA approved drugs to treat hemorrhoids
  11. B-Our Halo-Lido trial will have final patient by end of 2022
  12. G-I won't dilute shareholders
  13. G-I'm a shareholder myself
  14. G-I/Ontak is our lead asset
  15. G-Mino-Lok potential market >$1B
  16. B-An actual iMSC update
  17. O-Myron Holubiak and I founded a private company in 2013
  18. I-I/ONTAK was the best deal I ever made
  19. O-We have enough cash to go well into 2023
  20. N-I/ONTAK's potential market is >$300m
  21. I-We will have exclusivity
  22. N-We had a phase 2b trial with 100% efficacy
  23. B-Insiders invested $26.5m
  24. N-I/ONTAK was previously approved but taken off the market to improve manufacturing.